Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of fluvoxamine effect on tinnitus
IRCT2012101811157N1Phase 2Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of fluvoxamine in tinnitus and sensorineural hearing loss (SNHL), sponsored by Lorestan University of Medical Sciences. Started Sep 2012; status: completed.
02
Drugs
fluvoxamine
03
Conditions
tinnitussensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on IRCT2012101811157N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2012101811157N1.